Search clinical trials for: Discontinuation of CDK4/6 inhibitor Abemaciclib
Total 998 results
-
Institut für Klinische Krebsforschung IKF GmbH...Recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Safeway FoundationRecruiting
-
RenJi HospitalRecruiting
-
Henan Cancer HospitalRecruitingDigestive System TumorsChina
-
Mridula George, MDRecruiting
-
Hunan Cancer HospitalNot yet recruitingBreast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
-
Erasmus Medical CenterActive, not recruiting
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Taixing People's HospitalRecruiting
-
G1 Therapeutics, Inc.CompletedHealthy VolunteersNetherlands
-
G1 Therapeutics, Inc.CompletedHealthy VolunteersNetherlands
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
G1 Therapeutics, Inc.RecruitingExtensive-stage Small-cell Lung CancerSpain, Greece, Turkey, Poland, Georgia, Austria, Belgium, Bulgaria, Germany, Hungary
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced HR+ HER2 Negative Breast Carcinoma
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoUnknownMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
Fudan UniversityRecruitingBreast Cancer | Advanced Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Assistance Publique - Hôpitaux de ParisCompletedSurgery | Renin Angiotensin SystemFrance
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Yongsheng WangJiangsu HengRui Medicine Co., Ltd.RecruitingLocally Advanced Breast Cancer | Hormone Receptor Positive，HER2-negative Breast CancerChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Recruiting
-
G1 Therapeutics, Inc.TerminatedSmall Cell Lung CancerUnited States, Croatia, Belgium, Slovakia, Bosnia and Herzegovina, North Macedonia, Serbia, Slovenia
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Borstkanker Onderzoek GroepActive, not recruitingBreast Neoplasm FemaleNetherlands
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
Hunan Cancer HospitalCompletedMetastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
-
G1 Therapeutics, Inc.TerminatedColorectal Cancer Metastatic | Chemotherapeutic Toxicity | Myelosuppression-AdultChina, Spain, United States, Hungary, United Kingdom, Poland, Ukraine, Italy
-
VA Office of Research and DevelopmentCompleted
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
University of CalgaryCompleted
-
Lebanese UniversityHaykel HospitalRecruitingCancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Chemotherapy | Solid Tumor | Immunotherapy | Targeted Therapy | Precision TherapyLebanon
-
Peking University Cancer Hospital & InstituteRecruiting
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingChronic Myeloid LeukemiaItaly
-
G1 Therapeutics, Inc.Active, not recruitingTriple Negative Breast CancerUnited States
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eli Lilly and Company; Genentech, Inc.; Kazia... and other collaboratorsRecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Brain | NTRK Family Gene Mutation | CDK Gene Mutation | PI3K Gene Mutation | ROS1 Gene Mutation | KRAS G12C MutationUnited States
-
Oslo University HospitalSuspendedGastrointestinal Stromal TumorNorway
-
Eli Lilly and CompanyCompletedBreast Cancer | Early-Stage Breast Carcinoma | Hormone Receptor Positive TumorUnited States, Canada, Korea, Republic of, Italy, Austria, Belgium, Germany, Netherlands, Spain, Taiwan
-
Melanoma Institute AustraliaNovartisRecruiting
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
University of Sao Paulo General HospitalUnknownLeukemia, Myeloid, Chronic-PhaseBrazil
-
Novartis PharmaceuticalsCompleted
-
Glenn J. HannaAdenoid Cystic Carcinoma Research Foundation; Cellestia Biotech AGRecruitingAdenoid Cystic Carcinoma | Metastatic Adenoid Cystic Carcinoma | Recurrent Adenoid Cystic CarcinomaUnited States
-
University of PennsylvaniaUniversity of Arizona; Jordana B. Cohen, MD, MSCE; Thomas C. Hanff, MD, MPH; Department... and other collaboratorsCompleted
-
University of California, San DiegoEli Lilly and CompanyActive, not recruitingLung CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
University Hospital, Gentofte, CopenhagenCompleted
-
Nataliya UbohaEli Lilly and CompanyTerminatedAdenocarcinoma | Gastroesophageal CancerUnited States
-
University of Milano BicoccaCompleted